e-learning
resources
Vienna 2012
Monday, 03.09.2012
Viral infections and rare respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The clinical evaluation of respiratory tract infection caused by MRSA
K. Nakashima, Y. Otsuka, H. Kobayashi, N. Katsurada, N. Asai, H. Makino, M. Misawa, Y. Ohkuni, N. Kaneko, M. Aoshima (Kamogawa, Japan)
Source:
Annual Congress 2012 - Viral infections and rare respiratory infections
Session:
Viral infections and rare respiratory infections
Session type:
Thematic Poster Session
Number:
2545
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Nakashima, Y. Otsuka, H. Kobayashi, N. Katsurada, N. Asai, H. Makino, M. Misawa, Y. Ohkuni, N. Kaneko, M. Aoshima (Kamogawa, Japan). The clinical evaluation of respiratory tract infection caused by MRSA. Eur Respir J 2012; 40: Suppl. 56, 2545
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines
Source: Eur Respir J 2011; 37: 112-118
Year: 2011
Impact of appropriate diagnostics on the management of respiratory tract infections
Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Year: 2021
Does antibiotic treatment of upper respiratory tract infections prevent bacterial LRTIs?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009
Treatment of community-acquired lower respiratory tract infections in adults
Source: Eur Respir J 2002; 20: 40S-53S
Year: 2002
The role of atypical pathogens in the respiratory failure caused by lower respiratory tract infections
Source: Eur Respir J 2003; 22: Suppl. 45, 151s
Year: 2003
Lower respiratory tract infections: diagnosis and treatment in clinical practice
Source: International Congress 2014 – Primary Care Programme "Management of COPD and other respiratory conditions in clinical practice"
Year: 2014
The management of severe sepsis in respiratory tract infections
Source: Annual Congress 2013 –ME14 The management of severe sepsis in respiratory tract infections
Year: 2013
Prevalence of respiratory pathogens in children hospitalized with lower respiratory tract infection
Source: Eur Respir J 2007; 30: Suppl. 51, 398s
Year: 2007
Influence of antibiotic resistance of
pseudomonas aeruginosa
on presenting features of community-acquired lower respiratory tract infections
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011
Molecular characterisation and clinical presentation of Mycoplasma pneumoniae lower respiratory tract infections in children
Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes
Year: 2018
Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021
Radiological and microbiological findings in lower respiratory tract infections in HIV infected patients
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007
Clinical and radiological features can help predict Mycoplasma pneumoniae lower respiratory tract infection in children
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021
Guidelines for management of adult community-acquired lower respiratory tract infections
Source: Guideline 1998
Year: 1998
MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis
Source: ERJ Open Res 2016
Year: 2016
Incidence and severity of viral respiratory tract infections in immunocompromised children
Source: Annual Congress 2009 - Paediatric respiratory epidemiology: respiratory infections and rare diseases
Year: 2009
Monitoring opportunistic microflora in patients with HIV infection and highlighting the significance of Streptococcus gr. viridans in the development of lower respiratory tract infections
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
The role of respiratory viruses in the respiratory failure caused by lower respiratory tract infections
Source: Eur Respir J 2003; 22: Suppl. 45, 516s
Year: 2003
Fatal outcome in lower respiratory tract infections
Source: Eur Respir J 2004; 24: Suppl. 48, 186s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept